Baxter - 39 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of March 30, 2020 is 82.19.
- The all-time high Baxter stock closing price was 93.30 on February 06, 2020.
- The Baxter 52-week high stock price is 95.00, which is 15.6% above the current share price.
- The Baxter 52-week low stock price is 69.10, which is 15.9% below the current share price.
- The average Baxter stock price for the last 52 weeks is 83.02.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 86.3744 | 85.8700 | 93.3000 | 71.5700 | 82.1900 | -1.71% |
| 2019 | 79.7233 | 65.3000 | 89.7800 | 64.4800 | 83.6200 | 27.04% |
| 2018 | 69.8944 | 67.1700 | 77.8000 | 61.4500 | 65.8200 | 1.83% |
| 2017 | 58.0264 | 44.4400 | 66.0500 | 44.4400 | 64.6400 | 45.78% |
| 2016 | 43.8994 | 37.1700 | 49.1600 | 34.7600 | 44.3400 | 16.23% |
| 2015 | 52.9969 | 73.3100 | 73.3100 | 32.2700 | 38.1500 | -47.95% |
| 2014 | 72.2730 | 69.1900 | 77.0000 | 66.4900 | 73.2900 | 5.38% |
| 2013 | 69.3542 | 67.6500 | 74.4300 | 63.8900 | 69.5500 | 4.34% |
| 2012 | 58.0275 | 50.5400 | 68.8100 | 49.0300 | 66.6600 | 34.72% |
| 2011 | 54.3502 | 50.5500 | 62.4100 | 47.6500 | 49.4800 | -2.25% |
| 2010 | 49.9003 | 58.2900 | 61.7100 | 40.4700 | 50.6200 | -13.74% |
| 2009 | 54.0204 | 55.0800 | 60.5000 | 46.4100 | 58.6800 | 9.50% |
| 2008 | 61.4454 | 57.7900 | 71.1500 | 48.5000 | 53.5900 | -7.68% |
| 2007 | 54.7795 | 46.5000 | 61.0900 | 46.3300 | 58.0500 | 25.13% |
| 2006 | 40.9353 | 38.3600 | 47.2100 | 35.4500 | 46.3900 | 23.21% |
| 2005 | 37.2682 | 34.6200 | 40.9500 | 33.3700 | 37.6500 | 9.00% |
| 2004 | 31.4834 | 30.1700 | 34.5900 | 28.7600 | 34.5400 | 13.17% |
| 2003 | 26.5794 | 28.6900 | 31.2000 | 18.5600 | 30.5200 | 9.00% |
| 2002 | 43.1442 | 53.1000 | 59.6000 | 24.2200 | 28.0000 | -47.79% |
| 2001 | 48.4272 | 44.8150 | 55.5000 | 40.7500 | 53.6300 | 21.46% |
| 2000 | 35.8150 | 30.6900 | 44.4400 | 25.9050 | 44.1550 | 40.60% |
| 1999 | 32.7239 | 31.5950 | 37.9700 | 29.3450 | 31.4050 | -2.24% |
| 1998 | 28.6442 | 25.0650 | 33.0000 | 24.3450 | 32.1250 | 27.38% |
| 1997 | 25.1378 | 20.3150 | 29.7500 | 20.3150 | 25.2200 | 23.02% |
| 1996 | 21.9332 | 20.8100 | 23.9375 | 20.0000 | 20.5000 | -2.10% |
| 1995 | 17.7909 | 14.0650 | 21.2500 | 13.5650 | 20.9400 | 46.95% |
| 1994 | 12.7748 | 12.1900 | 14.3150 | 11.0000 | 14.2500 | 16.90% |
| 1993 | 13.4814 | 15.9400 | 15.9400 | 10.1250 | 12.1900 | -24.71% |
| 1992 | 17.9988 | 19.6250 | 20.0650 | 15.3750 | 16.1900 | -19.05% |
| 1991 | 16.9144 | 13.6900 | 20.1900 | 12.8150 | 20.0000 | 43.47% |
| 1990 | 12.3140 | 12.7500 | 14.5000 | 10.3150 | 13.9400 | 11.52% |
| 1989 | 10.7476 | 8.8100 | 12.8100 | 8.8100 | 12.5000 | 41.88% |
| 1988 | 10.3560 | 11.6850 | 12.9350 | 8.2500 | 8.8100 | -22.55% |
| 1987 | 12.1138 | 9.5000 | 14.5600 | 9.1850 | 11.3750 | 18.18% |
| 1986 | 9.0744 | 7.7500 | 10.5600 | 7.6250 | 9.6250 | 22.22% |
| 1985 | 7.3046 | 6.5650 | 8.3100 | 6.2500 | 7.8750 | 19.95% |
| 1984 | 8.1495 | 11.6250 | 12.2500 | 6.0000 | 6.5650 | -43.53% |
| 1983 | 13.3763 | 11.5925 | 15.6575 | 10.6850 | 11.6250 | -3.89% |
| 1982 | 9.6983 | 8.5625 | 12.6250 | 7.8125 | 12.0950 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $40.475B | $11.362B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $131.482B | 23.01 |
| Medtronic (MDT) | Ireland | $120.468B | 16.20 |
| Stryker (SYK) | United States | $59.680B | 19.28 |
| Boston Scientific (BSX) | United States | $42.738B | 19.25 |
| Coloplast (CLPBY) | Denmark | $29.624B | 45.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $29.586B | 0.00 |
| Terumo (TRUMY) | Japan | $24.707B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $24.477B | 0.00 |
| ResMed (RMD) | United States | $20.528B | 35.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.596B | 12.06 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.397B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.257B | 0.00 |
| Insulet (PODD) | United States | $11.048B | 675.96 |
| Bio-Rad Laboratories (BIO) | United States | $9.648B | 45.09 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.714B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.668B | 19.18 |
| Perrigo (PRGO) | Ireland | $6.275B | 11.44 |
| GN STORE NORD (GNNDY) | Denmark | $5.486B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.097B | 0.00 |
| Haemonetics (HAE) | United States | $5.078B | 31.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Quidel (QDEL) | United States | $3.950B | 34.67 |
| ICU Medical (ICUI) | United States | $3.899B | 25.46 |
| Neogen (NEOG) | United States | $3.088B | 52.31 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.652B | 0.00 |
| NuVasive (NUVA) | United States | $2.447B | 18.92 |
| Agios Pharmaceuticals (AGIO) | United States | $2.403B | 0.00 |
| Envista Holdings (NVST) | United States | $2.359B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.316B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.599B | 26.93 |
| AtriCure (ATRC) | United States | $1.227B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.204B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.197B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.075B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.879B | 0.00 |
| Aphria (APHA) | $0.879B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $0.820B | 16.21 |
| VAREX IMAGING (VREX) | United States | $0.770B | 15.99 |
| InMode (INMD) | Israel | $0.705B | 0.00 |
| Cerus (CERS) | United States | $0.702B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.642B | 0.00 |
| PetIQ (PETQ) | United States | $0.606B | 16.50 |
| Omeros (OMER) | United States | $0.602B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.549B | 32.63 |
| OraSure Technologies (OSUR) | United States | $0.504B | 62.54 |
| Quanterix (QTRX) | United States | $0.482B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.481B | 10.82 |
| LeMaitre Vascular (LMAT) | United States | $0.458B | 25.80 |
| Surmodics (SRDX) | United States | $0.455B | 52.34 |
| Vapotherm (VAPO) | United States | $0.364B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.363B | 0.00 |
| Owens & Minor (OMI) | United States | $0.347B | 9.50 |
| Zynex (ZYXI) | United States | $0.338B | 36.79 |
| HEXO (HEXO) | $0.310B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.301B | 12.12 |
| Utah Medical Products (UTMD) | United States | $0.292B | 20.88 |
| Repro-Med Systems (KRMD) | United States | $0.291B | 183.00 |
| MacroGenics (MGNX) | United States | $0.286B | 0.00 |
| Female Health (VERU) | United States | $0.214B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.212B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.192B | 117.38 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.162B | 18.30 |
| Rockwell Medical (RMTI) | United States | $0.151B | 0.00 |
| United Health Products (UEEC) | United States | $0.148B | 0.00 |
| Evolus (EOLS) | United States | $0.139B | 0.00 |
| Bovie Medical (APYX) | United States | $0.124B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.124B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.110B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 6.76 |
| Chimerix (CMRX) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.072B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.069B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.069B | 0.00 |
| United-Guardian (UG) | United States | $0.061B | 12.86 |
| Nephros (NEPH) | United States | $0.059B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.054B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.052B | 0.00 |
| Surface Oncology (SURF) | United States | $0.051B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.019B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.001B | 0.00 |
